Platelet 17 of aplastic anemia in a 36-week pregnant woman requires general, surgical, and pharmacological treatment managed by both an obstetrician and a hematologist. 1. General treatment: For mild patients in the middle and late stages of pregnancy, supportive treatment can be taken for observation, mainly through strengthening nutrition during pregnancy, intermittent oxygen intake, small amount of intermittent fresh blood input followed by component transfusion according to the blood index, including white blood cells, concentrated red blood cells or platelets, to relieve the signs of anemia. 2. Surgery: patients with aplastic anemia should have a cesarean section under the premise of stabilized condition. At 36 weeks of pregnancy, the baby’s organs have already matured, and it is usually possible for the baby to survive. 3. Medication: When the patient gives birth, a certain dose of hysteronin injection can be given to prevent postpartum hemorrhage, and antibiotics, such as penicillin sodium for injection, ceftazidime for injection and so on, can be used to prevent postpartum infection. When there is obvious bleeding tendency, adrenocorticotropic hormone should be given. Patients should follow the doctor’s instructions to actively cooperate with the doctor’s treatment, do not self-medication, so as not to delay the condition or cause adverse reactions.